Build up and tear down - Recensione dipendente - Quality Assurance presso Catalent Pharma

3,0
15 lug 2014
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Since 2008 a very disciplined management structure with clear reporting and accountability. Lot of competence and knowledge through an international organization and many people are easy to approach. Good programs for EHS, talent reviews, leadership development.

Svantaggi

There is a clear story line: Catalent needs to go public and for that needs to be profitably growing quarter by quarter. Anything else is sacrificed. If a growth plan is rubbish nobody can say that, as it may impact momentum or enthusiasm. That is going on now for a long time. Most of the managers with an own mind have left the company already and what is remaining survives only by passing pressure through. In consequence they do no appear strong, efficient leaders for their reports.

Esplora altre recensioni su Catalent Pharma

5,0
26 mag 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

The team is incredibly welcoming, knowledgeable, and supportive, which has made it easy to learn and feel comfortable asking questions. There is a strong focus on training and collaboration, helping me feel safe, well prepared, and confident in my role. I also appreciate the benefits, which support a good work-life balance.

Svantaggi

One area for improvement is the flexibility for new employees regarding remote work hours.

1,0
26 feb 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

-Colleagues in labs and manufacturing sites are knowledgeable, dedicated, and supportive of one another. - Compensation and benefits remain competitive within the contract development and manufacturing industry. - Employees gain meaningful hands-on experience with advanced gene therapy and biologics projects. - Certain facilities feature modern equipment that supports complex production requirements. - Occasional team events and basic perks help build occasional positive moments in the workplace.

Svantaggi

- The executive team consists primarily of finance professionals with limited direct experience in biopharmaceutical operations and quality systems. - Substantial debt accumulation and strategic divestitures occurred without sufficient investment in core manufacturing infrastructure or process improvements. - High employee turnover and repeated layoffs have led to increased workloads, reduced staffing levels, and declining team morale. - Persistent gaps in training, documentation, and maintenance contribute to quality deviations and regulatory compliance difficulties. - Communication between departments is often limited, resulting in unrealistic timelines and frequent project delays. - The company faced significant financial pressures approaching instability prior to the private acquisition. - Professional development opportunities are minimal, recognition is inconsistent, and work-life balance remains challenging for most roles

4
Vedi recensioni per: Utile|Valutazione|Data|Tutto